GCS is addressing the challenge of producing high-quality cells for drug discovery, vaccine development, the treatment of disease and other therapeutic uses. Its two primary products, GCS Microcarriers and Automated Bioreactor Systems, represent patent-pending technologies that will perform cell culturing more efficiently and at tremendously lower costs.
U.Va. Founders: Robin A. Felder